ICY:FRA
Incyte Corp
၉၇.၈၆ €
arrow_upward
+၁.၉၆%(+၁.၈၈) 1D
အောက် ၁၅, GMT+၂ ၀၈:၀၁:၂၈ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICY...
Open
၉၇.၈၆ €
High
၉၇.၈၆ €
Low
၉၇.၈၆ €
Mkt. cap
ဋေ ၂.၂၆ ထ
Avg. vol.
၃၄.၀၀
Volume
၀.၀၀
52-wk high
၁၁၅.၄၀ €
52-wk low
၇၂.၈၀ €
No. of employees
၃ ထောင်
Open
၉၇.၈၆ €
High
၉၇.၈၆ €
Low
၉၇.၈၆ €
Mkt. cap
ဋေ ၂.၂၆ ထ
Avg. vol.
၃၄.၀၀
Volume
၀.၀၀
52-wk high
၁၁၅.၄၀ €
52-wk low
၇၂.၈၀ €
No. of employees
၃ ထောင်
News stories
From web sources and news partners
The Globe and Mail
·
ပြီးခဲ့သည့် ၁ ရက်
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Incyte stock price target maintained at $152 by H.C. Wainwright
TipRanks
·
ပြီးခဲ့သည့် ၃ ရက်
GEN İlaç Secures Exclusive Rights to Incyte Drugs in Türkiye and Azerbaijan
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees၂.၈၄ ထောင်
Founded၂၀၀၂
HeadquartersWilmington, ဒယ်လာဝဲပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteincyte.com